BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Collaboration Between Abbvie, Biogen and Pfizer

Access to the world’s largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a gene...

July 12, 2021 | News

Hummingbird Bioscience and MD Anderson To Advance Innovative Immunotherapies

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to produce majo...

July 12, 2021 | News

MiRXES Secures US$77 Million To Accelerate Multi-Cancer Early Detection

MiRXES Pte Ltd, a biotechnology company focused on improving and saving lives with RNA-powered disease early detection tests, announced today it has ...

July 12, 2021 | News

I-Mab Expands Next Generation Novel Oncology Therapeutics

I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel bio...

July 10, 2021 | News

Elekta optimizes treatment times for cancer patients

For the last several years, Elekta (EKTA-B.ST) has invested substantially in digitized service solutions to keep critical treatment machines up and running...

July 07, 2021 | News

Y-Biologics & Pierre Fabre enter into an agreement in the field of immuno-oncology

These antibodies have been functionally validated by the Pierre Fabre R&D teams for their specific properties on a pivotal immuno-oncology target actin...

July 06, 2021 | News

Roche to drive therapies to treat breast and lung cancer

According to Globocan, in 2020 the global burden of cancer increased to 19.3 million new cases and 10 million deaths[1]. Worldwide, the most common type of...

July 06, 2021 | News

SINOMED announces a clinical collaboration with the National University of Ireland Galway

The PIONEER IV trial is a prospective, random trial that will take place in 30 hospitals across Europe, enrolling 2,540 patients and involve patient...

July 05, 2021 | News

BioMed X & Merck KGaA, Darmstad Launch New Research Program in Oncology

BioMed X Institute expands its collaboration with Merck KGaA, Darmstadt, Germany to a total of eight research programs. Call for application of ...

July 05, 2021 | News

Arctic Vision to develop innovative therapies for pan-ocular diseases

Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today...

July 05, 2021 | News

QIAGEN Forms Strategic Alliance With Sysmex Corporation

Frankfurt Prime Standard:QIA) today announced a global strategic alliance with Japan’s Sysmex Corporation (Tokyo Stock Exchange, First Section [Ticke...

July 02, 2021 | News

Alterity Therapeutics granted a new US patent

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the ...

July 02, 2021 | News

Pall Corporation Secures Multi-Million Dollar Contract With Exothera

Pall Corporation, a global leader in filtration, separation and purification, today announced a new contract worth more than $7M with full-service contract...

July 01, 2021 | News

OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies

OnCusp successfully closed its seed round financing of $25 million on April 1, 2021, led by Sequoia Capital and Biotrack Capital, followed b...

July 01, 2021 | News

Stay Connected